Sex differences in the pivotal MS clinical trials: what is the evidence?

被引：0
|
作者：
Bove, R. [1 ]
Houtchens, M. [2 ]
机构：
[1] Univ Calif San Francisco, Neurol, Sandler Neurosci Ctr, UCSF Neurol, San Francisco, CA 94143 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P926
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [41] Sex and Age Differences in MS Imaging Biomarkers
    Zeydan, B.
    Neyal, N.
    Son, J.
    Atkinson, E. J.
    Port, J. D.
    Kantarci, K.
    Kantarci, O. H.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 112 - 112
  • [42] Sample size re-estimation for pivotal clinical trials
    Liu, Yi
    Xu, Heng
    CONTEMPORARY CLINICAL TRIALS, 2021, 102
  • [43] Just and Equitable Enrollment to Pivotal Clinical Trials in Hematologic Malignancies
    Chandhok, Namrata S.
    Sekeres, Mikkael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (32) : 3677 - +
  • [44] Representation of Patients With Cardiovascular Disease in Pivotal Cancer Clinical Trials
    Bonsu, Janice
    Charles, Lawrence
    Guha, Avirup
    Awan, Farrukh
    Woyach, Jennifer
    Yildiz, Vedat
    Wei, Lai
    Jneid, Hani
    Addison, Daniel
    CIRCULATION, 2019, 139 (22) : 2594 - 2596
  • [45] No shortcuts to outcome in MS clinical trials?
    Koch-Henriksen, Nils
    NEUROLOGY, 2009, 72 (08) : 686 - 687
  • [46] MRI monitoring of MS in clinical trials
    Miller, DH
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 104 (03) : 236 - 243
  • [47] What has universal leucodepletion given us: evidence from clinical trials?
    van de Watering, L
    VOX SANGUINIS, 2004, 87 : 139 - 142
  • [48] Disability as an outcome in MS clinical trials
    Ebers, G. C.
    Heigenhauser, L.
    Daumer, M.
    Lederer, C.
    Noseworthy, J. H.
    NEUROLOGY, 2008, 71 (09) : 624 - 631
  • [49] Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?
    N Tunariu
    S B Kaye
    N M deSouza
    British Journal of Cancer, 2012, 106 : 619 - 628
  • [50] Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?
    Tunariu, N.
    Kaye, S. B.
    deSouza, N. M.
    BRITISH JOURNAL OF CANCER, 2012, 106 (04) : 619 - 628
12345